Vicenza deciphered: Modeling the von Willebrand disease enigma: Commentary on accelerated clearance alone explains ultralarge multimers in VWD Vicenza

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 6, 2010, Pages 1271-1272

  Goodeve, A C ^a,b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; RISTOCETIN; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ARTICLE; BLEEDING TIME; GENE MUTATION; HUMAN; MATHEMATICAL MODEL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIMULATION; VON WILLEBRAND DISEASE; VON WILLEBRAND DISEASE VICENZA;

HEMORRHAGE; HUMANS; VON WILLEBRAND DISEASES;

EID: 77954518209     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.03842.x     Document Type: Article

References (15)

1. Gezsi A, Budde U, Deak I, Nagy E, Mohl A, Schlammadinger A, Boda Z, Masszi T, Sadler JE, Bodo I. Accelerated clearance alone explains ultralarge multimers in VWD vicenza. J Thromb Haemost 2010, 8:1273-80.
2. Mannucci PM, Lombardi R, Castaman G, Dent JA, Lattuada A, Rodeghiero F, Zimmerman TS. von Willebrand disease "Vicenza" with larger-than-normal (supranormal) von Willebrand factor multimers. Blood 1988, 71:65-70.
3. Casonato A, Pontara E, Sartorello F, Cattini MG, Sartori MT, Padrini R, Girolami A. Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. Blood 2002, 99:180-4.
4. Casonato A, Pontara E, Sartorello F, Cattini MG, Gallinaro L, Bertomoro A, Rosato A, Padrini R, Pagnan A. Identifying type Vicenza von Willebrand disease. J Lab Clin Med 2006, 147:96-102.
5. Schneppenheim R, Federici AB, Budde U, Castaman G, Drewke E, Krey S, Mannucci PM, Riesen G, Rodeghiero F, Zieger B, Zimmermann R. Von Willebrand Disease type 2M "Vicenza" in Italian and German patients: identification of the first candidate mutation (G3864A; R1205H) in 8 families. Thromb Haemost 2000, 83:136-40.
6. Castaman G, Missiaglia E, Federici AB, Schneppenheim R, Rodeghiero F. An additional unique candidate mutation (G2470A; M740I) in the original families with von Willebrand disease type 2 M Vicenza and the G3864A (R1205H) mutation. Thromb Haemost 2000, 84:350-1.
7. Casana P, Cabrera N, Haya S, Cid AR, Aznar JA. Von Willebrand's disease: a novel mutation, P1824H and the incidence of R1205H defect among families with dominant quantitative von Willebrand factor deficiency. Haematologica 2006, 91:1130-3.
8. Hashemi Soteh SM, Anson J, Inbal A, Peake IR, Goodeve AC. Re-evaluation of three Israeli families initially diagnosed with type 1 von Willebrand disease in light of the ISTH update on von Willebrand factor pathophysiology and classification. Haemophilia 2008, 14:621-4.
9. Lester WA, Guilliatt AM, Surdhar GK, Enayat MS, Hill FGH. Inherited and de novo von Willebrand disease 'Vicenza' in UK families with the R1205H mutation. J Thromb Haemost 2003, (Supplement).
10. Cumming A, Grundy P, Keeney S, Lester W, Enayat S, Guilliatt A, Bowen D, Pasi J, Keeling D, Hill F, Bolton-Maggs PH, Hay C, Collins P. An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease. Thromb Haemost 2006, 96:630-41.
11. Goodeve A, Eikenboom J, Castaman G. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood 2007, 109:112-21.
12. James PD, Notley C, Hegadorn C, Leggo J, Tuttle A, Tinlin S, Brown C, Andrews C, Labelle A, Chirinian Y, O'Brien L, Othman M, Rivard G, Rapson D, Hough C, Lillicrap D. The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study. Blood 2007, 109:145-54.
13. van Schooten CJ, Shahbazi S, Groot E, Oortwijn BD, van den Berg HM, Denis CV, Lenting PJ. Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivo. Blood 2008, 112:1704-12.
14. Budde U, Pieconka A, Will K, Schneppenheim R. Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification. Semin Thromb Hemost 2006, 32:514-21.
15. Lenting PJ, Westein E, Terraube V, Ribba AS, Huizinga EG, Meyer D, de Groot PG, Denis CV. An experimental model to study the in vivo survival of von Willebrand factor. Basic aspects and application to the R1205H mutation. J Biol Chem 2004, 279:12102-9.